Yahoo Web Search

Search results

    • Samsung Biologics Reports First Quarter 2024 Financial Results

      Morningstar· 6 days ago

      Recorded Q1'24 consolidated revenue of KRW 946.9 billionRecorded Q1'24 consolidated operating profit of KRW 221.3 billionSustained growth driven by ongoing strategic expansion in capacity and portfolioINCHEON, South Korea, April 24, 2024 /PRNewswire